It has been a while since I owned UNIS and I sold out at a fair loss. Haven't been successful with any of my Biomed stock purchases - that might say something more about my investment rationale, or alternatively it might say something about how many Aussie (or others for that matter) Biomeds have actually made it.
The 'rumour' mill is a dangerous thing and there are clearly a few pumpers around who sound more like they should be at a casino than providing input in a Stock Investment forum - they are certainly not providing value to existing/potential holders here - in fact, the opposite.
Nothing negative from me about UNIS and the potential, although it has me beat what is going on here and why Pharma partners would let it hit the ground if they could buy a stake (perhaps there is something in their contracts that prevents this).
How are Unilife's competitors doing? I'm referring to other smaller players in the industry as opposed to any that might be trying to sell purely on the basis of innovation. Maybe there is a thought - maybe Unilife should also be taking a step back with a couple of 'plain vanilla' lines that allow them to offer some price competitive solutions, rather than solely innovative ones - that way, they can cover the spectrum and offer more on budget as well as innovation.
I'm also interested in thoughts on whether there is the potential for a private syndicate to conveniently takeover if UNIS does go down...and who might that private syndicate include? The real story often only becomes obvious and evident in hindsight...
